GlassScriptPhysician profile
Ann C Roberson
NPI 1265688865
$2,087.25
in general payments reported to CMS, 2019-2025
17 companies · $776 in 2025
The $776 reported for 2025 was more than what 93% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $75.25 · 2023: $367 · 2024: $869 · 2025: $776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,012.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $787.90 | 2024-2025 | Daxxify |
| Abbvie INC. | $545.66 | 2023-2025 | Skyrizi, Rinvoq |
| E.R. Squibb & Sons, L.L.C. | $172.17 | 2023-2025 | Sotyktu |
| Ucb, INC. | $107.05 | 2024-2025 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $78.91 | 2022-2025 | Ilumya |
| Lilly USA, LLC | $75.42 | 2022-2025 | Taltz, Olumiant, Ebglyss |
| Leo Pharma INC. | $62.91 | 2025 | Adbry, Anzupgo |
| Boston Scientific Corporation | $45.07 | 2022-2024 | |
| Genzyme Corporation | $39.94 | 2022-2023 | |
| Galderma Laboratories, L.P. | $31.47 | 2023 | |
| Mallinckrodt Hospital Products INC. | $30.70 | 2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $27.15 | 2023 | |
| Axsome Therapeutics, INC. | $20.72 | 2023 | Sunosi |
| Biofrontera INC. | $20.24 | 2024 | Rhodoled Xl, Xepi, Bf-Rhodoled |
| Grifols USA, LLC | $15.00 | 2024 | Gamunex-C |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $13.52 | 2024 | Vtama |
| Helsinn Therapeutics (U.S.), INC. | $13.42 | 2024 | Valchlor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Roberson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.